AMERICAN HEALTH PACKAGING — Paclitaxel Importer Profile
Pharmaceutical Importer · #8 buyer for Paclitaxel · $900.0K import value · 18 shipments · UNITED STATES · DGFT Verified
AMERICAN HEALTH PACKAGING is the #8 importer of Paclitaxel from India with $900.0K in import value and 18 verified shipments. AMERICAN HEALTH PACKAGING holds a 1.1% market share in Paclitaxel imports based in UNITED STATES. The company sources from 1 verified supplier across 6 formulations shipped to 1 country. Overall, AMERICAN HEALTH PACKAGING imports 2 pharmaceutical products worth $1.9M across 2 therapeutic categories.
AMERICAN HEALTH PACKAGING — Paclitaxel Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Paclitaxel to AMERICAN HEALTH PACKAGING?
Verified from 18 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MSN LABORATORIES PRIVATE LIMITED | $900.0K | 18 | 100.0% |
AMERICAN HEALTH PACKAGING sources Paclitaxel from 1 verified Indian supplier based on 18 customs records. The primary supplier is MSN LABORATORIES PRIVATE LIMITED accounting for 100.0% of imports.
How Does AMERICAN HEALTH PACKAGING Compare to Nearest Paclitaxel Importers?
Buyers ranked immediately above and below #8 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | ACCORD FARMACUTICA LTDA. | BRAZIL | $1.1M | 29 | $39.1K |
| 11 | FRESENIUS KABI COLOMBIA SAS | COLOMBIA | $1.0M | 25 | $41.7K |
| 8 | AMERICAN HEALTH PACKAGING ★ | UNITED STATES | $900.0K | 18 | $50.0K |
| 12 | NORTHSTAR DISTRIBUTION CENTER 8912, | UNITED STATES | $850.0K | 17 | $50.0K |
| 13 | NOVADOZ PHARMACEUTICALS LLC | UNITED STATES | $787.0K | 16 | $49.2K |
AMERICAN HEALTH PACKAGING ranks #8 among 959 Paclitaxel importers from India. Average shipment value of $50.0K compared to the market average of $30.0K. The closest competitors by value are ACCORD FARMACUTICA LTDA. and FRESENIUS KABI COLOMBIA SAS.
Where Does AMERICAN HEALTH PACKAGING Import Paclitaxel To?
Destination countries from 18 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $900.0K | 18 | 100.0% |
AMERICAN HEALTH PACKAGING imports Paclitaxel to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $900.0K.
What Paclitaxel Formulations Does AMERICAN HEALTH PACKAGING Import?
| Formulation | Value | Shipments |
|---|---|---|
| PACLITAXEL INJ 300MG /50ML(MSN PHARMACEUTICAL PRODUCT NAME)NOS | $350.0K | 7 |
| MSN PHARMA PACLITAXEL INJ 300MG /50ML | $300.0K | 6 |
| PACLITAXEL INJ 300MG /50ML | $100.0K | 2 |
| PACLITAXEL INJ 300MG/50ML | $50.0K | 1 |
| PACLITAXEL INJ 300MG/50ML (13817 X 1'S PACK = 13817 NOS) | $50.0K | 1 |
| Paclitaxel Inj 300mg 50ml | $50.0K | 1 |
AMERICAN HEALTH PACKAGING imports 6 distinct Paclitaxel formulations from India. The top formulation is PACLITAXEL INJ 300MG /50ML(MSN PHARMACEUTICAL PRODUCT NAME)N with 7 shipments worth $350.0K.
Regulatory Requirements: Importing Paclitaxel into United States
What AMERICAN HEALTH PACKAGING and other importers must comply with to import Paclitaxel from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Paclitaxel
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Paclitaxel from India and How Much Does AMERICAN HEALTH PACKAGING Import?
India exported $28.7M worth of Paclitaxel through 4,928 shipments from 319 suppliers to 142 countries, serving 959 buyers globally. AMERICAN HEALTH PACKAGING imports $900.0K of this total, accounting for 1.1% of India's Paclitaxel exports with 18 shipments from UNITED STATES. This is verified from 18 customs shipment records covering 6 distinct formulations.
What Is the Average Order Value for AMERICAN HEALTH PACKAGING's Paclitaxel Imports?
AMERICAN HEALTH PACKAGING's average Paclitaxel order value is $50.0K per consignment, based on 18 shipments totaling $900.0K. AMERICAN HEALTH PACKAGING is based in UNITED STATES and ranks #8 among all Paclitaxel importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Paclitaxel to AMERICAN HEALTH PACKAGING?
AMERICAN HEALTH PACKAGING sources Paclitaxel from 1 verified Indian supplier: MSN LABORATORIES PRIVATE LIMITED ($900.0K, 100.0%). This is based on 18 customs records.
How Does AMERICAN HEALTH PACKAGING Compare to Other Paclitaxel Importers?
AMERICAN HEALTH PACKAGING ranks #8 among 959 Paclitaxel importers from India with a 1.1% market share. The top 3 importers are FRESENIUS KABI DEUTSCHLAND GMBH ($17.2M), J. KNIPPER & COMPANY ($1.9M), MERMISI LLC ($1.1M). AMERICAN HEALTH PACKAGING processed 18 shipments from UNITED STATES.
About AMERICAN HEALTH PACKAGING
AMERICAN HEALTH PACKAGING imports 2 products worth $1.9M. Beyond Paclitaxel, top products include Nitrofurantoin. View the complete AMERICAN HEALTH PACKAGING profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Paclitaxel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Paclitaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: AMERICAN HEALTH PACKAGING matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as AMERICAN HEALTH PACKAGING's capped import value divided by total capped export value for Paclitaxel across all Indian exporters.
- 5.Verified Records: This page is backed by 18 individual customs records matching AMERICAN HEALTH PACKAGING importing Paclitaxel, covering 6 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 142+ countries, 959+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Paclitaxel Import Data for AMERICAN HEALTH PACKAGING
Access order-level details, pricing data, supplier connections, and competitive analysis for AMERICAN HEALTH PACKAGING's Paclitaxel imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AMERICAN HEALTH PACKAGING
Full Company Profile →
2 products · $1.9M total trade · 2 categories
AMERICAN HEALTH PACKAGING × Paclitaxel
Verified from customs records
Company Overview
Top Products by AMERICAN HEALTH PACKAGING
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for AMERICAN HEALTH PACKAGING.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Paclitaxel. For current order-level data, contact TransData Nexus.